Health Policy
WHO guidelines, EU directives, and Georgian health governance
Biotech Industry Faces Political Uncertainty and AI Profitability Questions at BIO 2026
Biotech executives at BIO 2026 confronted mounting concerns over Chinese competition, the uncertain profitability of AI-driven drug discovery, and political…
Editor's Top Picks
Eli Lilly’s Obesity Drug Access: What We Know About FDA Approval Pathways
Regulatory pathways and corporate strategy shape early access to obesity drug candidates. Pharmaceutical acquisitions in the metabolic disease sector reflect…
Submit Your Paper →
More form Health Policy
UK and US Regulators Launch Joint Liaison Programme to Strengthen Drug Approval Coordination
The UK Medicines and Healthcare products Regulatory Agency (MHRA) and US Food and Drug Administration…
Cancer mortality gap widens: wealthy urban areas see steep declines while rural regions lag behind
Cancer mortality in the US has dropped steeply since 1991, but the gains are concentrated…
Congenital Syphilis Surging in U.S.: A Physician’s Urgent Call for Action
Congenital syphilis rates in the United States are rising sharply, alarming physicians and public health…
How US immigration policy shapes maternal and child health outcomes
Immigration policy restrictions directly limit prenatal care access for undocumented women, reshaping family health decisions…
The Hidden Cost of Secrecy: How Missing Research Data Undermines Clinical Guidance
Systematic reviews and meta-analyses that guide clinical practice are increasingly compromised by lack of access…